Skip to main content

Why pay full price for medications?

See Prices Now

Why is Retatrutide called the ‘triple hormone’ drug?

Retatrutide is a next-generation weight loss medication from Eli Lilly that is currently in Phase 3 trials. It is nicknamed the “triple G” drug because it mimics 3 hunger-regulating hormones: GLP-1, GIP and glucagon. Retatrutide is a new approach to treat obesity and early results suggest it could cause more weight loss than other treatments.

Shop Medications

,

This includes tirzepatide, the active ingredient in Eli Lilly’s weight loss injection Zepbound and type 2 diabetes drug Mounjaro. It mimics 2 of the hormones, GLP-1 and GIP. While Wegovy, which is manufactured by Novo Nordisk, only works on GLP-1 to help you lose weight.

You can expect to see data from a late-stage trial of retatrutide later this year, a few months earlier than Eli Lilly anticipated.

Why Pay Full Price?

Search our full medication catalogue and save up to 80% - no insurance needed.

See Prices Now

Related Conditions